Constipation in Parkinson's disease: objective assessment and response to psyllium
For some individuals, particularly women approaching or in perimenopause, this shift can unmask or worsen androgenic alopecia, a pattern of hair thinning driven by dihydrotestosterone (DHT) sensitivity in genetically predisposed follicles
However, this does not prove that every symptom during weight loss is caused by toxicant mobilization, and current evidence has not established a unique GLP-1-related toxin release syndrome. Symptoms during GLP-1 treatment are more often explained by recognized medication effects, reduced food or fluid intake, dehydration, constipation, nutrient insufficiency, blood sugar changes, or gallbladder complications
There can be side effects and risks: GLP-1 drugs affect multiple systems (pancreas, kidney, GI tract) and are not without cost or health implications
Introducing Our Latest White Paper: Orforglipron: A Next-Generation Oral GLP-1 Agonist Were proud to share our newest research spotlighting Orforglipron, an innovative oral GLP-1 agonist poised to transform diabetes and obesity management